Health & Beauty

On the 6th, the "Sino-Russian Biomedicine International Engineering Science and Technology Strategy High-end Forum and the 13th Sino-Russian International Pharmacology Conference" was held in Harbin. Famous teachers at home and abroad gather online and offline to discuss cutting-edge topics in the field of biomedical science and technology, and experience the unique charm brought by academic sharing and thinking collisions under different cultural backgrounds, providing valuable opportunities for medical cooperation between the two countries and promoting the innovation and development of biomedicine .

The theme of this high-end forum is "Collaborative Innovation, Leading the Future". Chinese and foreign experts and scholars gathered together to give keynote reports on topics such as tumors, major heart diseases, rare diseases, rapid and accurate detection of pathogenic microorganisms, and biopharmaceuticals. The latest research progress of multiple disciplines in the field of biomedicine has effectively promoted the integration of medicine and engineering, and accelerated the pace of cutting-edge technological breakthroughs.

Promoting joint innovation in biomedical technology is the hottest topic and highlight of this conference. Yang Baofeng, chairman of the conference and academician of the Chinese Academy of Engineering, introduced: In recent years, biomedicine has shown great application potential in the fields of major infectious diseases, tumors and chronic disease prevention, and its importance has become increasingly prominent.

"As the main direction of strategic emerging industries in China's 14th Five-Year Plan, biomedicine is an important support point for promoting the construction of a healthy China." Academician Yang Baofeng said that the promotion of vaccines, antibodies, peptides, nucleic acid drugs and gene editing drugs and other new types of drugs The research and development and transformation of biomedicine will surely become the mainstream trend of the development of the pharmaceutical industry in China and even the world in the future.

At the same time, affected by the new crown epidemic, the global biopharmaceutical market demand continues to grow. As a country with a large demand in the biopharmaceutical market, China is vigorously strengthening the research and development and transformation of bioinnovative drugs. However, due to the constraints of technology and talents, compared with foreign markets There is a certain gap.

Academician Yang Baofeng pointed out that biomedicine is composed of the biotechnology industry and the pharmaceutical industry. As one of the most promising fields in Russia, biotechnology has reached the world's advanced level. Entering the new era, on the basis of previous cooperation, China and Russia should further deepen the cooperation in the field of medical science and technology, find the right point of convergence, and achieve complementary advantages.

The purpose of convening this academic forum is to focus on the forefront of international science and technology, based on and serve China's national innovation-driven development strategy, and conduct extensive discussions on how to give full play to the advantages of the alliance platform and deepen the exchanges and cooperation between China and Russia in the field of biomedicine. It will help to promote the formation of a new situation of innovation and development of the Sino-Russian biopharmaceutical industry.